$MEIP MEI Pharma Inc. (NASDAQ:MEIP): this is an exponential Northside call, the sector analysts sees it having a best-in-class PI3Kδ inhibitor, which has demonstrated strong risk-benefit profile in Phase 1 lymphoma trials. MEIP broke out on 6 April and has confirmed it Bull move, the Support is Strong at 2.53 and the Resistance is NIL, […]
$BAYRY Never before have the American People been affected by such a catastrophe, as no war has or will have the effect of a virus such as COVID-19 worldwide. In essence, the $21-T+ American economy at a standstill with millions of American families wondering how they will survive economically. About 40% live paycheck to paycheck […]
$APTO, $CDMO, $ENDP, $IGMS, $ILMN Here are some of the many biotech and pharma stocks that have been given big Northside targets for Y 2020 by Key sector analysts, as follows: Aptose Biosciences Inc. (NASDAQ:APTO) was started with a new Buy rating and a 10 price target at Piper Jaffray on 9 January. This represented […]
$ISEE, $KOD, $MYL, $NVCN, $PCRX, $XFOR Iveric Bio, Inc. (NASDAQ:ISEE) was started with a Buy rating and was assigned a $13 price target at Wedbush Securities on 7 January. Wedbush sees the stock as undervalued as its lead asset Zimura is set to begin a pivotal clinical study in Q-1 of Y 2020 in the […]
$ABBV, $BAX, $BIIB, $BMY, $BXX, $CELG, $MRK, $WST Biotech stocks had a muted performance last week, as Johnson & Johnson (NYSE:JNJ) kick started Q-2 reporting season for big pharma companies, beating forecasts and an upward adjustment to its FY sales guidance. Below are the Key catalysts for the week ahead, as follows: Conferences 10th International AIDS Society, or […]
Update: The Legal Status of CBD in the US $GWPH CBD is the nonpsychoactive component of cannabis and hemp. Unlike the THC in cannabis, CBD does not induce a high, but has many clinical benefits, including the control of seizures and pain Federal drug laws stipulate cannabis is an illegal Class 1 narcotic In states […]
Big Pharma Vs Hemp Based CBDs and Medical Marijuana $LLY, $GWPH The legal status of CBD oil, as a nutritional supplement is being threatened by Big Pharma seeking FDA approval for CBD-containing drugs The cannabinoids in cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), interact with the human body by way of naturally-occurring cannabinoid receptors embedded in […]
US DOJ Blocks Cannabis Research $GWPH, $AXIM, $POTN The Big Q: Is the Justice Department blocking cannabis research? The Big A: It sounds like it is When the US Drug Enforcement Agency (DEA) receives applications to grow cannabis for research, they have to send it to the US Department of Justice (DOJ) for final approval. […]
Medical Grade Marijuana, The Solution to America’s Opioid Addiction? $ENDP Last Thursday, the FDA took an unprecedented step in an attempt to curb America’s opioid abuse crisis, but that does not yet mean that medical grade marijuana will be more seriously considered as an alternative to the highly addictive and deadly heroin like Rx drugs. […]
Future Uncertain, as Speculators Pour Money into Cannabis Industry The adversarial stance of The Trump Administration’s toward cannabis has yellow lights flashing in the growing industry, but speculators’ money continues to pour in. Marijuana focused companies raised more than $731-M between 1 January and 21 April, an almost 7X increase from the same frame last […]